Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| OTCRX | Otter Creek Long/Short Opportunity Fund - Investor Class | $14.41 | $11.93 | 480.50% | - | - | - |
| PRAX | Praxis Precision Medicines | $162.71 | $105.36 | 1.84% | 13.7M | $1.2B | $26.7$205.89 |
| RYOJ | rYojbaba | $4.76 | $2.59 | 1.19% | 28.5M | $24.4M | $1.81$5.35 |
| APLM | Apollomics | $31.98 | $12.48 | 0.64% | 268.8K | $21.5M | $3.66$42.12 |
| ELWS | Earlyworks | $5.1 | $1.42 | 0.39% | 31.4M | $11.1M | $1.64$10.5 |
| RGTZ | Tidal Trust II - Defiance Daily Target 2x Short Rgti ETF | $11.23 | $2.53 | 0.29% | 48.5M | - | $8.14$20.39 |
| SNSE | Sensei Biotherapeutics | $17.58 | $3.9 | 0.29% | 122.3K | $17.2M | $5$18.35 |
| NXTC | NextCure | $8.7 | $1.89 | 0.28% | 352.9K | $18.2M | $2.69$19.2 |
| LGCB | Linkage Global | $1.97 | $0.32 | 0.19% | 51.9M | $22.4M | $1.22$6.83 |
| BIAF | bioAffinity Technologies | $3.41 | $0.7 | 0.26% | 20.4M | $5.0M | $2.34$67.12 |
Related Articles
Featured Article
This Cancer Detection Pioneer Is Worth a Look
Matthew Benjamin|Sep 26, 2025
Multicancer detection tests are closing in on FDA approval and potentially major sales.
3 Top Takeaways from J.B. Hunt's Outstanding Q3
Rhian Hunt|Oct 28, 2021
The company's big rigs are hauling in profits, though lack of truckers casts a shadow on its potential gains.
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
Cory Renauer|Sep 9, 2021
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.
This Penny Stock Is Built on Hype and Broken Promises
Leo Sun|Apr 30, 2021
Energous is trading at nearly half its IPO price for obvious reasons.
Sell-Off? Correction? These 3 Stocks Are Already 40% Off Their Highs
Rick Munarriz|Mar 23, 2021
In a little more than a month, these three stocks have surrendered between 42% and 47% of their value. This correction could use a correction.
If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now
Taylor Carmichael|Jan 23, 2021
Investors weren't very happy when shares tanked in March, but have been smiling ever since.
3 Stocks Under $10 That Have Already Doubled in 2020
Rick Munarriz|Sep 3, 2020
A producer of animated kids shows, a food delivery tech specialist, and a Chinese internet retailer have all more than doubled this year. They all still trade in the single digits.
3 Stocks Under $3 That Should Bounce Back in 2021
Rick Munarriz|Aug 25, 2020
A senior community specialist, online travel portal, and Chinese e-commerce speedster all trade for less than a Happy Meal. The catalysts are there for a heartier meal.
Personalis Turns to Liquid Biopsies for Growth. Will It Work?
Maxx Chatsko|Aug 14, 2020
The company, which leans on one customer for 76% of revenue, desperately needs to diversify its customer base.
NextCure Delays 2 Clinical Trials Due to Coronavirus
Eric Volkman|Apr 14, 2020
The company cited patient safety concerns and the current strains on hospitals as the reasons for the postponements.
